Boyu Capital primarily focuses on making significant private equity investments in established, large-scale Chinese companies across sectors like technology, healthcare, and consumer. Their strategy involves active engagement and strategic guidance to drive growth and operational improvements within their portfolio companies.
Portfolio
5
Fund Size
—
Top Stage
Series D
Last 12 Mo
0
Stage Distribution
Portfolio
5 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Zeekr Intelligent Technology Co. | Growth | $500M | Aug 2021 |
| Shanghai MediTrust Health Technology Co., Ltd. | Series C | $308M | Aug 2021 |
| Trax | Growth | $125M | Jul 2018 |
| Brii BioSciences | Series D | $260M | May 2018 |
| Megvii | Series D | $600M | — |
Top Co-Investors
Alliance Ventures1 shared
Marathon1 shared
Alibaba Group Holding Ltd.1 shared
ARCH Venture Partners1 shared
Sequoia Capital1 shared
Blue Pool Capital1 shared
Intel Capital1 shared
Last updated: 1 March 2026